Flash FinanceUS
Market closed · weekend S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · NeoGenomics Laboratories (NEO)

NeoGenomics names Warren Stone CEO effective Jan. 4, 2027; Q3 revenue about $209 million

Positive Impact 4 of 5 leadership Written later

NeoGenomics said its board chose President and COO Warren Stone as chief executive effective January 4, 2027, with current CEO Tony Zook becoming Executive Chairman. The company also reported preliminary, unaudited third quarter revenue of approximately $209 million and said full-year total revenue guidance is expected to increase at the midpoint, though the preliminary figures could change after quarter-end closing.

Key points

  • Warren Stone to become CEO effective January 4, 2027, with a base salary of $850,000 and a 100% target bonus
  • Preliminary Q3 2026 total revenue of approximately $209 million, with NGS revenue growth of approximately 28%
  • Full-year total revenue guidance expected to increase at the midpoint; adjusted EBITDA guidance reiterated from July 28, 2026
  • Board maximum size raised from 10 to 11 directors; Chair Lynn Tetrault steps down January 4, 2027 and will not stand for reelection in 2027

The filing

CompanyNeoGenomics Laboratories (NEO)
Form8-K, current report
Filed with the SECOct 5, 2026, 4:08 PM ET
Accession number0001077183-26-000069

Items reported: 2.02 Results of Operations5.02 Director / Officer Change5.03 Bylaw / Charter Amendment

Read the filing on SEC.gov ↗

Written by AI (Anthropic Claude, claude-haiku-5-5) on Nov 8, 2026, 6:56 AM ET, from the text of the filing and its press-release exhibits only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on October 05, 2026.

Briefs are written by AI from the filing text (each brief's own page names the model) and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the model's reading of the filing for shareholders, not a price forecast. Not investment advice.